Gerry - thank you for the reply and addressing the

New Post Public Reply Private Reply Replies (1) Message Board
thesmalls Gerrytheb #13080
Gerry - thank you for the reply and addressing the question:

"Before they are able to attract investors they must first show revenue and growth, otherwise they could put out a million PRs and still only attract traders"

I dont understand the logic behind this. Are they referring to showing revenue on the books or signed contracts? Generally, the companies I follow put out PRs for major contract signings when they are completed - not when said revenues hit the books. The point is to inform investors of the material event and prove viability (for growing/emerging companies). This is where PPS becomes critical from a company standpoint and not individual investor standpoint - it is their primary source of leverage (perceived and actual) towards gaining capital at attractive terms AND gaining larger, longer term investors which provide long term PPS stability and installed investor base for secondary offerings (if needed). By that rationale - they should be informing these potential investors now and making them aware the company has turned the corner towards production from R&D phase AND they have guaranteed contracts on the book to give a clear path towards company meeting guidance. These investors absorb supply from traders, have a longer time horizon (which reduce volatiliy), and become a source to attract more of the same. There are multiple levels of risk for any class of investors and you arent going to attract institutional investors with ANY PR when trading just above trips. However, you can bring in new longer term investors (like myself) that look for real value and potential in emerging companies. Right now - this is nothing but a trading stock/dumping ground for MMs due to the uncertainty and constant cryptic messaging from IR. I am certainly not the only one that has asked or addressed IR looking for more clarity with their posts or answers. Further, since IR has already publicly and privately labeled me a "basher" - they arent exactly a good source for me to address questions to. On the flip side - Bill has been the opposite which he has demonstrated on the past CCs and on the phone which anyone will that has spoken to him willusually attest to.

It isnt a matter of impatience - its a matter of fundamentals and focus on the company part. I would argue I have/had a longer term horizon than 90%+ on here (not that most will admit it). I havent sold any shares since I started buying at 0.0002 even though I should have above 0.005. Instead- I was buying on the way down and more aggressively as it tanked - UNTIL the reconstruction and uncertainty came in. That was exasperated by the emergence of IR and VNDM showing up at the same time and then OS going from 1.8 to over 3 BB. Part of that was an error addressed by Bill. However - end of 2015/beginning of 2016 he was talking about getting under 1BB OS on buybacks and through M&A. Now we are 3.4BB and IR is talking 400-800MM in 6 months or so. The current guidance for EOY revenue does NOT support cash flow to make that happen. Even if the loan comes in it would be tough. The fundamentals have changed and are unclear. That is a concern. If/when they book revenue that shows they are back on track to plan and able to sustain cash flow to make that happen - it will be a much smaller concern.

OTC stocks rarely trade on fundamentals but if they are going to succeed long term - they will DO to them.

As far as happy/unhappy - that is somewhat irrelevant. Debating fundamentals, perceptions, interpretations, IR responses, intent is not bitching, whining, or complaining. It is ferreting out details and unknowns so that individual investors can properly balance the risk and reward to their own risk profile. This notion that any questioning is negative is not only absurd but destructive. Maybe that is the goal.

For the company to hit their several times now stated goal of 0.01 PPS by EOY- they HAVE to attract a lot of new and long term minded investors. Period. The more they let the stock fluctuate and increase volatility, the more traders/overhead they will attract that will specifically retard that process. They have 3 months left. They have committed to about $75-250K in revenues so far to hit 2016 books. That is NOT going to give the company a market cap of $35MM which would be what it takes to hit a penny. $13.5MM "guaranteed " a year for 10 years does that at under 3X sales not to mention the EIA potential and other SLAs. The longer they wait - the higher the volatility. Doesnt make sense (if the SLA is guaranteed). If it isnt - then IR was less than forthcoming in past communication. To me, he made it pretty clear that $13.5MM could be considered minimum guidance for 2017.

Finally - pointing out negatives and objections and having someone objectively and resolutely counter them is one of the surest ways to close a sale/win a debate. Arbitrarily dismissing them or diminishing their importance only magnifies their significance in the eyes of those holding them.

Trans-Pacific Aerospace (TPAC) Stock Research Links

TPAC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

M&A Source's 2026 Conference Tackles Deal-Making Drama

Updated Category News Views 84

High Stakes and Deep Insights Await in Houston Cracking the nut of lower-middle market transactions ain’t a walk in the park. M&A Source®'s Fall 2026 Conference is gearing up to address the very dramas that lurk behind the scenes. Kicking off November 2-4 at the opulent JW Marriott in Houston, Texas, the event is looking to assemble a heavyweight lineup of...

Continue Reading
Co-Diagnostics Nearing India TB Test Launch By 2026

Updated Category News Views 98

Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...

Continue Reading
Tamara Toles O'Laughlin: Steering Philanthropy's Next Era

Updated Category News Views 52

Leadership Transition in Philanthropy Everyone knows the drill: leadership changes are often a toss-up. You could get a fresh burst of energy or spend years longing for the good old days. That's where The New York Women's Foundation finds itself as they hand over the reins from Ana L. Oliveira to Tamara Toles O'Laughlin. In a world where philanthropic shifts can either...

Continue Reading
Fairfax Crest: A New Chapter in Affordable Housing

Updated Category News Views 31

Setting the Stage: Fairfax Crest's Grand Opening You know what's better than leaving a dusty old car park underutilized? Turning it into homes for folks who really need them. That's exactly what went down in Fairfax County as they cut the ribbon on their latest affordable housing project, Fairfax Crest. We're talking 279 affordable units sprouting up where there once lay...

Continue Reading
Hisense's AI S7 Dishwasher Revolutionizes Home Living

Updated Category News Views 75

The Intersection of AI and Home Appliances In a world where families are looking for more efficiency, Hisense isn’t just tossing another dishwasher into the wild. No, they're aiming to redefine the whole damn experience of household chores with their latest brainchild, the Hisense S7 Dishwasher. Packed with AI smarts and an impressive tech bouquet, this bad boy is all...

Continue Reading
Personalis Merger Faces Investigation: $16.25 Offers Scrutinized

Updated Category News Views 38

Market Storm or Light Drizzle? When the sharks smell blood or the legal eagles start circling, you know something stinks. BFA Law is sniffing around, and it isn’t just for sport. They’re putting their magnifying glass on this curious $16.25 per share transaction where Tempus AI plans to gobble up Personalis lock, stock, and barrel. For investors holding NASDAQ:PSNL,...

Continue Reading
XCMG Climbs Fortune China 500: Strengthens Global Edge

Updated Category News Views 83

XCMG's Ascent on the Fortune China 500 When it comes to scaling new heights, XCMG Machinery is clearly in the driver's seat, roaring up the Fortune China 500 to claim the 202nd spot, leaping ten ranks from last year. While others may coast, XCMG's trajectory is anything but idle, retaining its crown among Chinese construction machinery titans. The recent summit in Chengdu...

Continue Reading
Common Thread Advisors: Transforming Change in Business

Updated Category News Views 41

Navigating the Storm of Change: A New Player in Town You know, just when you think you've got the business world figured out, something sharp comes along. Today, it’s Common Thread Advisors, making its grand entrance to help organizations steer through the dense fog of change. This isn’t your everyday, run-of-the-mill consultancy. No sir, they’re out here with a...

Continue Reading
Bybit’s Gold Yield Offer: 2.83% APR on XAUT

Updated Category News Views 74

Gold Savings with a Tokenized Twist Taking a wild swing at pairing gold and crypto in a digestible package, Bybit and the XAUE Protocol have teamed up to offer a 2.83% fixed APR on XAUT Savings. If you're itching for something that doesn’t make your stomach churn like some of the wild crypto rides, this just might soothe those nerves. Or maybe it’s just a slick way to...

Continue Reading
Fluence Faces Legal Battle Amid Major Stock Plunge

Updated Category News Views 55

The High Stakes for Fluence Energy Investors Well, here's a plot twist, or perhaps not for those who've been keeping an eye on the renewable energy sector. Fluence Energy (NASDAQ:FLNC), a supposed heavyweight in energy storage and renewable innovations, is tangled in a legal web over securities fraud. As of now, Fluence has been slapped with a class action lawsuit...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionizing Safety Monitoring with LifeSphere Advanced Signals

Updated Category News Views 244

Revolutionizing Pharmacovigilance with AI In the realm of life sciences, ensuring patient safety is paramount. Recently, a prominent pharmaceutical organization announced its partnership with ArisGlobal in implementing the innovative LifeSphere Advanced Signals. This advanced pharmacovigilance solution utilizes automation and AI-driven insights to enhance signal detection...

Continue Reading
Arcellx Inc. Under Fire: Shareholder Concerns Mounting Fast

Updated Category News Views 163

What's Going Down with Arcellx? Kickin’ off with the news—Arcellx Inc. (NASDAQ: ACLX) is under the microscope for potential shareholder shenanigans. I mean, there’s chatter coming from the Ademi Firm, pointing fingers at the board for not playing fair with the shareholders. Not exactly a good look, right? This takes me back to times when I’ve seen boards pulling...

Continue Reading
Memecoins Rally: The Strategic Advantage of Investing in PEPE

Updated Category News Views 164

The Surge of Pepe and Shiba Inu in Recent Days In a surprising turn of events, the memecoins Pepe and Shiba Inu have experienced remarkable gains amidst a largely negative market atmosphere. While the broader cryptocurrency market has been facing some challenges, these two coins have struck a positive chord with traders and investors alike. Market Performance: Gains...

Continue Reading
Transforming the Electrical Grid: Lessons from Advanced Technologies

Updated Category News Views 176

Modernizing the Electrical Grid: An Urgent Need As the demand for energy continues to increase, the necessity for a robust and efficient electrical grid becomes increasingly evident. States across the nation are actively seeking solutions to modernize their utilities and ensure a reliable energy supply. One of the most promising approaches involves the implementation of...

Continue Reading
WEX Inc. CFO's Recent Stock Sale: Implications for Investors

Updated Category News Views 122

WEX Inc. CFO's Notable Stock Sale WEX Inc. (NYSE: WEX) Chief Financial Officer Jagtar Narula recently made headlines by selling 508 shares of the company's stock. Priced at $200 each, this sale totaled an impressive $101,600. Transactions of this magnitude naturally attract attention from both investors and market analysts. Context Behind the Sale The sale occurred under...

Continue Reading